Water-soluble aluminium phthalocyanine for cancer treatment
Author Information
Author(s): Brasseur N, Ouellet R, Madeleine C La, Lier J E van
Primary Institution: MRC Group in the Radiation Sciences, Faculty of Medicine, Université de Sherbrooke
Hypothesis
The study investigates the effectiveness of water-soluble aluminium phthalocyanine derivatives as sensitizers for photodynamic therapy in cancer treatment.
Conclusion
The addition of hydrophilic ligands to aluminium phthalocyanine improves its pharmacokinetics without reducing its photodynamic therapy efficiency.
Supporting Evidence
- The light dose required to kill 90% of cells was significantly lower for AlClPc compared to its derivatives.
- All three dye preparations induced complete tumour regression in 75-100% of animals at a low drug dose.
- AlPc–PVA showed a prolonged plasma half-life compared to AlClPc and AlPc–PEG.
Takeaway
Scientists created a new version of a cancer treatment that dissolves better in water, making it easier to use, and it works just as well as the older version.
Methodology
The study evaluated the photodynamic activities of two water-soluble derivatives of aluminium phthalocyanine in vitro and in vivo against specific tumour models in mice.
Participant Demographics
Balb/c mice bearing EMT-6 and Colo-26 tumours.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website